Small Molecules Targeting Human UDP‐GlcNAc 2‐Epimerase
ChemBioChem · 2023
DOI: 10.1002/cbic.202300555 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2023. Verfasst von Jacob L Gorenflos López und 14 weiteren Autor:innen. Beteiligte Einrichtung: Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany. Hauptthemen laut MEDLINE: N-Acetylneuraminic Acid, Carbohydrate Epimerases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Uridine diphosphate N ‐acetylglucosamine 2‐epimerase (GNE) is a key enzyme in the sialic acid biosynthesis pathway. Sialic acids are primarily terminal carbohydrates on glycans and play fundamental roles in health and disease. In search of effective GNE inhibitors not based on a carbohydrate scaffold, we performed a high‐throughput screening campaign of 68,640 drug‐like small molecules against recombinant GNE using a UDP detection assay. We validated nine of the primary actives with an orthogonal real‐time NMR assay and verified their IC 50 values in the low micromolar to nanomolar range manually. Stability and solubility studies revealed three compounds for further evaluation. Thermal shift assays, analytical size exclusion, and interferometric scattering microscopy demonstrated that the GNE inhibitors acted on the oligomeric state of the protein. Finally, hydrogen‐deuterium exchange mass spectrometry (HDX‐MS) revealed which sections of GNE were shifted upon the addition of the inhibitors. In summary, we have identified three small molecules as GNE inhibitors with high potency in vitro , which serve as promising candidates to modulate sialic acid biosynthesis in more complex systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.
- Humboldt Universität zu Berlin, Department Chemie, Brook-Taylor-Strasse 2, 12489, Berlin, Germany.
- Freie Universität Berlin, Institut für Pharmazie, Biopharmazeutika, Kelchstr. 31, 12169, Berlin, Germany.
- Berliner Hochschule für Technik (BHT), Seestrasse 64, 13347, Berlin, Germany.
- TECAN Group Ltd., Untersbergstraße 1a, 5082, Grödig, Austria.
ORCID-Profile: Christian P R Hackenberger
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Gorenflos López, J. L., Dornan, G. L., Boback, N., Neuenschwander, M., Oder, A., Kemnitz-Hassanin, K., Schmieder, P., Specker, E., Asikoglu, H. C., Oberdanner, C., Seyffarth, C., von Kries, J. P., Lauster, D., Hinderlich, S., & Hackenberger, C. P. R. (2023). Small Molecules Targeting Human UDP‐GlcNAc 2‐Epimerase. ChemBioChem. https://doi.org/10.1002/cbic.202300555
Vancouver
Gorenflos López JL, Dornan GL, Boback N, Neuenschwander M, Oder A, Kemnitz-Hassanin K, et al. Small Molecules Targeting Human UDP‐GlcNAc 2‐Epimerase. ChemBioChem. 2023. doi:10.1002/cbic.202300555
BibTeX
@article{GorenflosLpez2023,
author = {Gorenflos López, Jacob L and Dornan, Gillian L and Boback, Nico and Neuenschwander, Martin and Oder, Andreas and Kemnitz-Hassanin, Kristin and Schmieder, Peter and Specker, Edgar and Asikoglu, Hatice Ceyda and Oberdanner, Christian and Seyffarth, Carola and von Kries, Jens Peter and Lauster, Daniel and Hinderlich, Stephan and Hackenberger, Christian P R},
title = {Small Molecules Targeting Human UDP‐GlcNAc 2‐Epimerase},
journal = {ChemBioChem},
year = {2023},
doi = {10.1002/cbic.202300555}
}
EUVIMED